Properties (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Celgene_Corporation
|
| gptkbp:awards |
Best Places to Work
Top_Employer_UK |
| gptkbp:clinicalTrials |
oncology
cardiovascular diseases immunology real-world evidence studies patient-centric approaches collaborative trials |
| gptkbp:communityEngagement |
health awareness campaigns
patient support programs |
| gptkbp:corporateSocialResponsibility |
community health programs
healthcare_access_initiatives |
| gptkbp:employees |
approximately 1,000
|
| gptkbp:financialPerformance |
revenue growth
investment in R&D profit_margins |
| gptkbp:focusArea |
biopharmaceuticals
|
| gptkbp:founded |
1984
|
| gptkbp:globalPresence |
gptkb:Latin_America
gptkb:North_America gptkb:Asia-Pacific Middle_East |
| gptkbp:headquarters |
gptkb:Uxbridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bristol-Myers Squibb UK
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
gene therapy
biologics new drug development |
| gptkbp:leadership |
CEO
executive team |
| gptkbp:market |
global
European_market UK_market |
| gptkbp:operatesIn |
gptkb:United_Kingdom
|
| gptkbp:parentCompany |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:partnerships |
academic institutions
research institutions biotech companies healthcare_organizations |
| gptkbp:products |
cancer treatments
immunology drugs cardiovascular drugs |
| gptkbp:regulatoryCompliance |
EMA_approved_drugs
FDA_approved_drugs |
| gptkbp:research_areas |
cardiology
neurology oncology rare diseases hematology infectious diseases immunology |
| gptkbp:researchAndDevelopment |
clinical trials
|
| gptkbp:sustainabilityInitiatives |
diversity and inclusion efforts
environmental responsibility programs |
| gptkbp:website |
www.bms.com/uk
|